OncoTargets and Therapy

译名:肿瘤靶点与治疗

SCIEJCR Q3
预警期刊

1-3

2026

影响因子区间

平台估算

投稿周期

69%

2025

中国作者发文占比

40000000 IRR;600 USD

费用说明

收费

期刊简介:OncoTargets and Therapy is an international, peer-reviewed journal focusing on molecular aspects of cancer research, that is, the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. The journal is characterized by the rapid reporting of high-quality original research, basic science, reviews and evaluations, expert opinion and commentary that shed novel insight on a cancer or cancer subtype. Specific topics covered by the journal include: -Novel therapeutic targets and innovative agents-Novel therapeutic regimens for improved benefit and/or decreased side effects-Early stage clinical trialsFurther considerations when submitting to OncoTargets and Therapy: -Studies containing in vivo animal model data will be considered favorably. -Tissue microarray analyses will not be considered except in cases where they are supported by comprehensive biological studies involving multiple cell lines. -Biomarker association studies will be considered only when validated by comprehensive in vitro data and analysis of human tissue samples. -Studies utilizing publicly available data (e.g. GWAS/TCGA/GEO etc.) should add to the body of knowledge about a specific disease or relevant phenotype and must be validated using the authors’ own data through replication in an independent sample set and functional follow-up. -Bioinformatics studies must be validated using the authors’ own data through replication in an independent sample set and functional follow-up. -Single nucleotide polymorphism (SNP) studies will not be considered.

【译文】《OncoTargets and Therapy》是一本国际同行评审期刊,专注于癌症研究的分子方面,即所有类型癌症的分子诊断和靶向分子或精准治疗。该期刊的特点是快速报道高质量的原创研究、基础科学、综述和评估、专家意见和评论,为癌症或癌症亚型提供新的见解。期刊涵盖的具体主题包括:-新型治疗靶点和创新药物-新型治疗方案以提高疗效和/或减少副作用-早期临床试验

出版社
Dove Medical Press
语言
English
学科
医学
ISSN
1178-6930
eISSN
1178-6930
出版频率
年刊
创刊年份
2008
投稿网址
https://www.dovepress.com/submit_step_1.php
最近更新
2026-04-02 18:16:40
OncoTargets and Therapy

指标当前值近三年趋势
JCR分区Q3
暂无
影响因子区间1-3
暂无